Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00065988 · ClinicalTrials.gov registry record · Phase 3

The Children's Amalgam Trial

A Phase 3 study of Dental Caries, sponsored by Carelon Research.

Completed
Registry status
Phase 3
Development phase
534
Enrollment target
1
Study location

NCT00065988: Completed Phase 3 study of Dental Caries, sponsored by Carelon Research.

NCT00065988 is a Phase 3 study of Dental Caries that has completed, run by Carelon Research. The registered enrollment target is 534 participants, below the 704-participant average among 30 other Dental Caries trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00065988, a Phase 3 study of Dental Caries, has completed, sponsored by Carelon Research.

COMPLETED
Registry status
Phase 3
Development phase
534 participants
Enrollment target
1
Study location

Study Summary

The Children's Amalgam Trial is one of only two randomized trials of its kind, and the only such trial in the United States, to address the potential impact of mercury exposure from amalgam restorations on neuropsychological and renal function in children.

Conditions Studied

Interventions

  • DEVICE Dispersed phase amalgam restoration /composite restoration

Study Locations (1)

Massachusetts

  • New England Research Institute - Watertown

Trial Details

FieldValue
Enrollment Target 534 participants
Start Date 1997-09
Est. Completion 2005-03
Phase Phase 3
Carelon Research

50 total trials

What the finished NCT00065988 record still lists

NCT00065988 is an interventional study that assigns participants to a tested intervention. The registered 534 participants enrollment target is mid-sized for trials with a published cap, below the 704-participant average among 30 other Dental Caries trials with a reported enrollment target (24% lower).

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 1 intervention - of which Dispersed phase amalgam restoration /composite restoration is the first listed.

NCT00065988 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00065988 about?

NCT00065988 is a clinical study titled "The Children's Amalgam Trial". The Children's Amalgam Trial is one of only two randomized trials of its kind, and the only such trial in the United States, to address the potential impact of mercury exposure from amalgam restorations on neuropsychological and renal function in children.

What is the current status of trial NCT00065988?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 534 participants. The study started on 1997-09. Estimated completion is 2005-03.

What conditions does trial NCT00065988 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT00065988?

The interventions under investigation include: Dispersed phase amalgam restoration /composite restoration (DEVICE).

Who is sponsoring clinical trial NCT00065988?

This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00065988 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00065988's enrollment target sits among peer trials

534 7th of 30 higher than 24 of 30 other Dental Caries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dental Caries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04910685 · 534 participants · Phase 2

    (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

  • NCT06128551 · 534 participants · Phase 1

    Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • NCT05614739 · 535 participants · Phase 1

    FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

  • NCT07091617 · 535 participants · NA

    Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00065988, the US trial registry maintained by the National Library of Medicine. NCT00065988 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.